Aleksandra Rizo

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

Martin Dreyling, Wojciech Jurczak, Mats Jerkeman et al. · The Lancet · 2015 · 462 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Repression of BMI1 in normal and leukemic human CD34+ cells impairs self-renewal and induces apoptosis

Aleksandra Rizo, Sandra Olthof, Lina Han et al. · Blood · 2009 · 178 citations · Full text

Life Sciences, Cell Biology, Hematology +8

Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL

Fritz Offner, Olga Samoilova, Evgenii A. Osmanov et al. · Blood · 2015 · 135 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7

Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion–Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

David P. Steensma, Pierre Fenaux, Koen Van Eygen et al. · Journal of Clinical Oncology · 2020 · 125 citations · Full text

Medicine, Hematology, Pharmacology +13

Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis

John Mascarenhas, Rami S. Komrokji, Francesca Palandri et al. · Journal of Clinical Oncology · 2021 · 104 citations

Medicine, Hematology, Pharmacology +13